Live Price
Live Volume
Altimmune Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $1.41 |
|---|---|
| Close | $1.42 |
| Low | $1.40 |
| Low Change | -0.01 (-0.71%) |
| High | $1.43 |
| High Change | +0.02 (+1.42%) |
| Range | $0.03 |
| Volume | 364.21K |
| Dollar Volume | $516.70K |
Regular Trading Hours Yesterday
| Open | $1.40 |
|---|---|
| Close | $1.41 |
| Low | $1.38 |
| Low Change | -0.02 (-1.43%) |
| High | $1.45 |
| High Change | +0.05 (+3.57%) |
| Range | $0.07 |
| Volume | 3.875M |
| Dollar Volume | $5.46M |
Premarket Yesterday
| Open | $1.41 |
|---|---|
| Close | $1.40 |
| Low | $1.39 |
| Low Change | -0.02 (-1.42%) |
| High | $1.42 |
| High Change | +0.01 (+0.71%) |
| Range | $0.03 |
| Volume | 53.082K |
| Dollar Volume | $74.36K |
Altimmune News
4 months agoinvesting.comWhy is Altimmune stock surging today?
4 months agoinvesting.comAltimmune stock surges 18% on positive trial results
7 months agobenzinga.comWhy Is Altimmune Stock Falling Today?
10 months agoinvesting.comAltimmune stock falls after announcing $75 million direct offering
10 months agoinvesting.comALT Technologies to be acquired by CCL Industries
11 months agoinvesting.comAltimmune stock soars after FDA grants Breakthrough Therapy status
11 months agoinvesting.comAltimmune stock tumbles after MASH drug trial data
Altimmune Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Altimmune Moving Averages
| 5 Day Moving Average (SMA5) | $1.51 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.72 |
| 20 Day Moving Average (SMA20) | $1.89 |
| 50 Day Moving Average (SMA50) | $2.43 |
| 100 Day Moving Average (SMA100) | $2.74 |
| 200 Day Moving Average (SMA200) | $3.05 |
Altimmune Statistics
| Average Volume (30 Days) | 3.96M |
|---|---|
| P/E Ratio (Current) | -2.57 |
| EPS (Current) | -$0.54 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$102.47M |
| Cash Ratio | 2.51 |
| Current Ratio | 23.93 |
| Quick Ratio | 23.93 |
| Debt to Equity | 0.08 |
| Enterprise Value | $276.58M |
| EV to EBITDA | -2.41 |
| EV to Sales | 10637.71 |
| Price to Book | 0.61 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 10403.05 |
| Return on Assets | -0.21% |
| Return on Equity | -0.24% |
Altimmune Stock Splits
There have been 3 stock splits for Altimmune (ALT). The last reverse stock split occured on September 14, 2018 and reduced the outstanding shares at a ratio of 30:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 14, 2018 | Reverse | 30:1 |
| May 4, 2017 | Reverse | 10:1 |
| Jul 25, 2007 | Reverse | 50:1 |
Altimmune Dividends
There have been no dividends for Altimmune (ALT).